1 정민유, "Two-Year Body Composition Analyses of Long-Lived GHR Null Mice" GERONTOLOGICAL SOC AMER 65 (65): 31-40, 201001
2 Trainer PJ, "Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant" 342 : 1171-1177, 2000
3 Kopchick JJ, "Transgenic models of growth hormone action" 19 : 437-461, 1999
4 Goffin V, "The human growth hormone antagonist B2036 does not interact with the prolactin receptor" 140 : 3853-3856, 1999
5 Mode A, "The human growth hormone (hGH) antagonist G120Rh- GH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the prolactin receptor" 137 : 447-454, 1996
6 Kumar PA, "The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy" 7 : 50-55, 2011
7 Orian JM, "The expression of a metallothionein- ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver" 124 : 455-463, 1989
8 Izzard AS, "The cardiovascular phenotype of a mouse model of acromegaly" 19 : 413-419, 2009
9 Pearce KH Jr, "Structural and mutational analysis of affinity-inert contact residues at the growth hormone- receptor interface" 35 : 10300-10307, 1996
10 Hauck SJ, "Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse" 226 : 552-558, 2001
11 Ikeno Y, "Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice" 64 : 522-529, 2009
12 Hara K, "Recombination of the biologically active peptides from a tryptic digest of bovine growth hormone" 17 : 550-556, 1978
13 Cunningham BC, "Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis" 243 : 1330-1336, 1989
14 Fuh G, "Rational design of potent antagonists to the human growth hormone receptor" 256 : 1677-1680, 1992
15 Bellush LL, "Protection against diabetes-induced nephropathy in growth hormone receptor/ binding protein gene-disrupted mice" 141 : 163-168, 2000
16 Miquet JG, "Prolonged exposure to GH impairs insulin signaling in the heart" 47 : 167-177, 2011
17 Nilsson L, "Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue" 331 : 1120-1126, 2005
18 Pradhananga S, "Pegvisomant: structure and function" 29 : 11-14, 2002
19 Arman A, "Novel growth hormone receptor gene mutation in a patient with Laron syndrome" 23 : 407-414, 2010
20 Chen WY, "Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice" 266 : 2252-2258, 1991
21 Palmiter RD, "Metallothionein- human GH fusion genes stimulate growth of mice" 222 : 809-814, 1983
22 Sherlock M, "Medical therapy in acromegaly" 7 : 291-300, 2011
23 Al-Regaiey KA, "Longlived growth hormone receptor knockout mice: interaction of reduced insulin- like growth factor i/insulin signaling and caloric restriction" 146 : 851-860, 2005
24 van der Lely AJ, "Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist" 358 : 1754-1759, 2001
25 Frick F, "Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice" 281 : E1230-E1239, 2001
26 Clark R, "Long-acting growth hormones produced by conjugation with polyethylene glycol" 271 : 21969-21977, 1996
27 Laron Z, "Laron syndrome: from man to mouse" Springer 2011
28 Panici JA, "Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans" 64 : 1126-1133, 2009
29 Wilson ME, "Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys" 85 : 1557-1562, 2000
30 Flyvbjerg A, "Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice" 48 : 377-382, 1999
31 Yakar S, "Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice" 113 : 96-105, 2004
32 Cecim M, "Infertility in transgenic mice overexpressing the bovine growth hormone gene: disruption of the neuroendocrine control of prolactin secretion during pregnancy" 52 : 1187-1192, 1995
33 Bollano E, "Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene" 141 : 2229-2235, 2000
34 Veldhuis JD, "Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men" 87 : 5737-5745, 2002
35 de Vos AM, "Human growth hormone and extracellular domain of its receptor: crystal structure of the complex" 255 : 306-312, 1992
36 Quaife CJ, "Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice" 124 : 40-48, 1989
37 Cunningham BC, "High-resolution epitope mapping of hGHreceptor interactions by alanine-scanning mutagenesis" 244 : 1081-1085, 1989
38 Knapp JR, "Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes" 72 : 2812-2819, 1994
39 Egecioglu E, "Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice" 290 : E317-E325, 2006
40 Guevara-Aguirre J, "Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans" 3 : 70ra13-, 2011
41 Kopchick JJ, "Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly" 23 : 623-646, 2002
42 Machado MO, "Growth hormone promotes glomerular lipid accumulation in bGH mice" 68 : 2019-2028, 2005
43 Bohlooly-Y M, "Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia" 54 : 51-62, 2005
44 Liu ZH, "Growth hormone expression is required for the development of diabetic glomerulosclerosis in mice" 51 : S37-S38, 1995
45 Berryman DE, "Growth hormone and adipose tissue: beyond the adipocyte" 21 : 113-123, 2011
46 Thorner MO, "Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH" 84 : 2098-2103, 1999
47 Shea BT, "Growth allometry of the organs in giant transgenic mice" 121 : 1924-1930, 1987
48 Chen WY, "Glycine 119 of bovine growth hormone is critical for growth-promoting activity" 5 : 1845-1852, 1991
49 Barkan AL, "Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant" 90 : 5684-5691, 2005
50 Yang CW, "Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene" 39 : S90-S94, 1993
51 Doi T, "Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels" 173 : 1287-1290, 1991
52 Yang CW, "Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice" 68 : 62-70, 1993
53 Chen WY, "Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice" 129 : 1402-1408, 1991
54 Cecim M, "Expression of human, but not bovine, growth hormone genes promotes development of mammary tumors in transgenic mice" 1 : 431-437, 1994
55 Chen WY, "Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice" 87 : 5061-5065, 1990
56 List EO, "Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse" 32 : 356-386, 2011
57 Bartke A, "Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice" 36 : 550-558, 2004
58 Wolf E, "Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models" 68 : 71-87, 1993
59 Wilson ME, "Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism" 83 : 4013-4021, 1998
60 Berryman DE, "Effect of growth hormone on susceptibility to diet-induced obesity" 147 : 2801-2808, 2006
61 Palmiter RD, "Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes" 300 : 611-615, 1982
62 Bartke A, "Does growth hormone prevent or accelerate aging" 33 : 675-687, 1998
63 Bonkowski MS, "Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity" 4 : e4567-, 2009
64 Liu JL, "Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice" 287 : E405-E413, 2004
65 Cunningham BC, "Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule" 254 : 821-825, 1991
66 Pomp D, "Development of obesity following inactivation of a growth hormone transgene in mice" 5 : 13-23, 1996
67 Coschigano KT, "Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span" 144 : 3799-3810, 2003
68 Coschigano KT, "Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span" 144 : 3799-3810, 2003
69 Huffman DM, "Contribution of adipose tissue to health span and longevity" 37 : 1-19, 2010
70 Kaps M, "Components of growth in mice hemizygous for a MT/bGH transgene" 77 : 1148-1154, 1999
71 Dominici FP, "Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice" 166 : 579-590, 2000
72 Berryman DE, "Comparing adiposity profiles in three mouse models with altered GH signaling" 14 : 309-318, 2004
73 Muller AF, "Clinical review 166: growth hormone receptor antagonists" 89 : 1503-1511, 2004
74 Laron Z, "Classification of growth hormone insensitivity syndrome" 122 : 241-, 1993
75 Bartke A, "Can growth hormone (GH) accelerate aging? Evidence from GHtransgenic mice" 78 : 210-216, 2003
76 Olsson B, "Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes" 285 : E504-E511, 2003
77 Olsson B, "Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet" 146 : 920-930, 2005
78 Eckstein F, "Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender" 12 : 116-125, 2002
79 Tran TT, "Beneficial effects of subcutaneous fat transplantation on metabolism" 7 : 410-420, 2008
80 정민유, "Age-Related Changes in Body Composition of Bovine Growth Hormone Transgenic Mice" ENDOCRINE SOC 150 (150): 1353-1360, 200903
81 Wang Z, "Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie- restricted mice" 148 : 2845-2853, 2007
82 Trainer PJ, "ACROSTUDY: the first 5 years" 161 (161): S19-S24, 2009
83 Bass SH, "A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor" 4498-4502, 1991
84 van der Lely AJ, "A six week, double blind, placebo controlled study of a growth hormone antagonist, B2036-PEG (Trovert) in acromegalic patients" 57-, 1998
85 Zhou Y, "A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)" 13215-13220, 1997
86 Chen NY, "A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin" 137 : 5163-5165, 1996
87 Okada S, "A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes" 130 : 2284-2290, 1992
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KCI
